AInvest Newsletter
Daily stocks & crypto headlines, free to your inbox
Adaptimmune Therapeutics PLC (ADAP) has disclosed that Chief Financial Officer Gavin Wood has executed a transaction, selling 96,000 shares at a price of $0.01 per share on September 2, 2025.

Daily stocks & crypto headlines, free to your inbox
Comments
No comments yet